Article
Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing.
British journal of cancer - 15 Jul 2014
Patton S, Normanno N, Blackhall F, Murray S, Kerr K M, Dietel M, Filipits M, Benlloch S, Popat S, Stahel R, Thunnissen E
Abstract excerpt
BACKGROUND: The external quality assurance (EQA) process aims at establishing laboratory performance levels. Leading European groups in the fields of EQA, Pathology, and Medical and Thoracic Oncology collaborated in a pilot EQA scheme for somatic epidermal growth factor receptor (EGFR) gene mutational analysis in non-small-cell lung cancer (NSCLC). METHODS: EQA samples generated from cell lines mimicking clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.